Antimicrobial Stewardship & Healthcare Epidemiology (Jan 2023)

Remdesivir use and antimicrobial stewardship restrictions during the coronavirus disease 2019 (COVID-19) pandemic in the United States: A cross-sectional survey

  • Alfredo J. Mena Lora,
  • Rodrigo Burgos,
  • Scott Borgetti,
  • Lelia H. Chaisson,
  • Susan C. Bleasdale

DOI
https://doi.org/10.1017/ash.2023.146
Journal volume & issue
Vol. 3

Abstract

Read online

Deploying therapeutics for coronavirus disease 2019 (COVID-19) has proved challenging due to evolving evidence, supply shortages, and conflicting guideline recommendations. We conducted a survey on remdesivir use and the role of stewardship. Use differs significantly from guidelines. Hospitals with remdesivir restrictions were more guideline concordant. Formulary restrictions can be important for pandemic response.